Ticker >

Zenlabs Ethica share price

Zenlabs Ethica Ltd.

BSE: 530697 SECTOR: Trading  6698   5   0

45.17
0 0
BSE: 26 Apr 04:01 PM

Price Summary

Today's High

₹ 45.17

Today's Low

₹ 44

52 Week High

₹ 70

52 Week Low

₹ 31.3

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

29.41 Cr.

Enterprise Value

30.74 Cr.

No. of Shares

0.65 Cr.

P/E

0

P/B

2.95

Face Value

₹ 10

Div. Yield

0.55 %

Book Value (TTM)

₹  15.31

CASH

1.64 Cr.

DEBT

2.97 Cr.

Promoter Holding

52.98 %

EPS (TTM)

₹  -0.19

Sales Growth

-3.19%

ROE

5.14 %

ROCE

10.34%

Profit Growth

-37.44 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-3.19%
3 Year3.72%
5 Year-1.42%

Profit Growth

1 Year-37.44%
3 Year36.88%
5 Year-15.91%

ROE%

1 Year5.14%
3 Year7.83%
5 Year5.79%

ROCE %

1 Year10.34%
3 Year13.44%
5 Year10.5%

Debt/Equity

0.306

Price to Cash Flow

19.35

Interest Cover Ratio

2.26476654790924

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 52.98 0
Dec 2023 59.12 0
Sep 2023 59.12 0
Jun 2023 59.12 0
Mar 2023 59.12 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of 8.65421382647079 days.
  • The company has a high promoter holding of 52.98%.

 Limitations

  • The company has shown a poor revenue growth of 3.71718364416811% for the Past 3 years.
  • Company has a poor ROE of 7.82908013260002% over the past 3 years.
  • The company has a low EBITDA margin of 2.5381900231515% over the past 5 years.
  • The company is trading at a high PE of 0.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 17.4 14.6 13.57 14.06 15.6
Total Expenditure 16.83 14.12 13.04 13.63 14.91
Operating Profit 0.57 0.48 0.53 0.43 0.69
Other Income 0.03 0.04 0.05 0.22 0
Interest 0.15 0.14 0.16 0.21 0.22
Depreciation 0.31 0.32 0.32 0.32 0.32
Exceptional Items 0 -0.58 0 0 0
Profit Before Tax 0.14 -0.52 0.1 0.12 0.15
Tax 0.04 -0.13 0.03 0.04 0.04
Profit After Tax 0.1 -0.39 0.07 0.09 0.12
Adjusted EPS (Rs) 0.16 -0.6 0.1 0.14 0.18

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 67.3 59.95 56.64 69.09 66.89
Total Expenditure 65.27 60.67 54.9 66.69 63.98
Operating Profit 2.03 -0.72 1.74 2.4 2.9
Other Income 0.16 0.07 0.12 0.09 0.13
Interest 0.07 0.23 0.29 0.37 0.53
Depreciation 0.23 0.29 0.71 0.89 1.25
Exceptional Items 0 0 0 0 -0.58
Profit Before Tax 1.89 -1.17 0.86 1.22 0.67
Tax 0.63 -0.3 0.09 0.44 0.19
Net Profit 1.26 -0.87 0.77 0.78 0.49
Adjusted EPS (Rs.) 1.94 -1.33 1.18 1.2 0.75

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 6.51 6.51 6.51 6.51 6.51
Total Reserves 1.77 0.9 2.05 2.82 3.19
Borrowings 0.28 0.32 0.23 0.17 1.11
Other N/C liabilities 0.26 0.02 1.5 2.96 2.99
Current liabilities 26.07 25.89 21.45 25.2 29.45
Total Liabilities 34.89 33.65 31.75 37.66 43.26
Assets
Net Block 1.36 1.12 3.51 3.53 5.02
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0.7 0.7 0.7 0.7 0.7
Loans & Advances 0 0 0.05 0.03 0.04
Other N/C Assets 0 0 0 0 0
Current Assets 32.83 31.83 27.49 33.4 37.51
Total Assets 34.89 33.65 31.75 37.66 43.26
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 1.89 -1.17 0.86 1.22 0.67
Adjustment -0.36 0.75 0.92 1.18 2.27
Changes in Assets & Liabilities -0.73 0.87 -10.1 -2.66 -1.16
Tax Paid 0 0 -0.09 -0.12 -0.27
Operating Cash Flow 0.8 0.45 -8.41 -0.38 1.52
Investing Cash Flow -0.22 0.01 0.15 0 -1.47
Financing Cash Flow -0.14 -0.03 -0.52 0.31 0.06
Net Cash Flow 0.44 0.43 -8.78 -0.07 0.11

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
promoters 59.12 59.12 59.12 59.12 52.98
harjinder kaur 0.02 0.02 0.02 0.02 0.02
himjyoti 0.02 0.02 0.02 0.02 0.02
jasbir singh kalra - - - 0.02 0.02
preet remedies limited 32.73 32.73 32.73 32.73 26.58
sanjay dhir 13.18 13.18 13.18 13.18 13.18
sanjeev kumar singal - - - 13.17 13.17
jasbir singh 0.02 0.02 0.02 - -
sanjeev kumar singhal 13.17 13.17 13.17 - -
PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
investors 40.88 40.88 40.88 40.88 47.02
b s mallikarjuna 1.89 2.15 2.16 2.16 2.17
bhasakarrai kanyalal bhat... 1.86 1.86 1.86 1.86 1.86
hitesh popatlal oswal - - - - 6.79
rakesh kumar arora 1.19 1.19 1.19 1.19 1.19
venkata sasidhar pokuri 1.11 1.11 1.11 1.11 -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Zenlabs Ethica informs about details of loss of certificate 28 Feb 2024, 4:59PM Zenlabs Ethica - Quaterly Results29 Jan 2024, 1:14PM Zenlabs Ethica - Quaterly Results29 Jan 2024, 1:14PM Zenlabs Ethica - Quaterly Results29 Jan 2024, 1:14PM Zenlabs Ethica informs about press release7 Nov 2023, 3:02PM Zenlabs Ethica - Quaterly Results6 Nov 2023, 3:46PM Zenlabs Ethica - Quaterly Results6 Nov 2023, 3:46PM Zenlabs Ethica - Quaterly Results6 Nov 2023, 3:46PM Zenlabs Ethica - Quaterly Results28 Jul 2023, 4:46PM Zenlabs Ethica - Quaterly Results28 Jul 2023, 4:46PM Zenlabs Ethica - Quaterly Results28 Jul 2023, 4:46PM Zenlabs Ethica - Quaterly Results24 May 2023, 2:11PM Zenlabs Ethica - Quaterly Results24 May 2023, 2:11PM Zenlabs Ethica - Quaterly Results24 May 2023, 2:11PM Zenlabs Ethica - Quaterly Results9 Feb 2023, 3:44PM Zenlabs Ethica - Quaterly Results9 Feb 2023, 3:44PM Zenlabs Ethica - Quaterly Results9 Feb 2023, 3:44PM Zenlabs Ethica - Quaterly Results18 Oct 2022, 3:43PM Zenlabs Ethica - Quaterly Results18 Oct 2022, 3:43PM Zenlabs Ethica - Quaterly Results18 Oct 2022, 3:43PM Zenlabs Ethica - Quaterly Results20 Jul 2022, 4:23PM Zenlabs Ethica - Quaterly Results20 Jul 2022, 4:23PM Zenlabs Ethica - Quaterly Results20 Jul 2022, 4:23PM Zenlabs Ethica informs about appointment of CS cum CO30 Jun 2022, 5:22PM Zenlabs Ethica informs about closure of trading window30 Jun 2022, 1:50PM Zenlabs Ethica informs about disclosure21 Jun 2022, 9:51AM Zenlabs Ethica informs about newspaper publication11 May 2022, 4:36PM Zenlabs Ethica - Quaterly Results10 May 2022, 6:53PM Zenlabs Ethica - Quaterly Results10 May 2022, 6:53PM Zenlabs Ethica informs about clarification on price movement10 Jan 2022, 4:31PM Zenlabs Ethica informs about press release1 Nov 2021, 4:28PM Zenlabs Ethica informs about disclosure20 Aug 2021, 9:45AM Zenlabs Ethica informs about newspaper publication19 May 2021, 2:23PM Zenlabs Ethica informs about compliance certificate9 Apr 2021, 3:24PM Zenlabs Ethica informs about newspaper publication9 Feb 2021, 12:56PM Zenlabs Ethica informs about issuance of duplicate share certificate28 Nov 2020, 10:37AM Zenlabs Ethica informs about loss of share certificates19 Sep 2020, 3:34PM Zenlabs Ethica informs about disclosure on related party transactions6 Jul 2020, 3:51PM Zenlabs Ethica informs about compliance certificate20 May 2020, 3:19PM

Zenlabs Ethica Stock Price Analysis and Quick Research Report. Is Zenlabs Ethica an attractive stock to invest in?

 

Stock investing requires careful analysis of financial data to find out the company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement. This can be time-consuming and cumbersome. An easier way to find out about a company's performance is to look at its financial ratios, which can help to make sense of the overwhelming amount of information that can be found in a company's financial statements.

Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings' ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Zenlabs Ethica has a PE ratio of -241.035218783351 which is low and comparatively undervalued .

  • Share Price: - The current share price of Zenlabs Ethica is Rs 45.17. One can use valuation calculators of ticker to know if Zenlabs Ethica share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Zenlabs Ethica has ROA of 1.20922450724657 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Zenlabs Ethica has a Current ratio of 1.27349092415404 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Zenlabs Ethica has a ROE of 5.14038082731451 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Zenlabs Ethica has a D/E ratio of 0.306 which means that the company has low proportion of debt in its capital.

  • Inventory turnover ratio: - Inventory Turnover ratio is an activity ratio and is a tool to evaluate the liquidity of a company's inventory. It measures how many times a company has sold and replaced its inventory during a certain period of time. Zenlabs Ethica has an Inventory turnover ratio of 6.68075670708564 which shows that the management is inefficient in relation to its Inventory and working capital management.

  • Sales growth: - Zenlabs Ethica has reported revenue growth of -3.18638022921558 % which is poor in relation to its growth and performance.

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Zenlabs Ethica for the current financial year is 4.34034422543299 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Zenlabs Ethica is Rs 0.25 and the yield is 0.5535 %.

Last Updated on:
Brief about Zenlabs Ethica
X